Related Experiment Video
Updated: Mar 23, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma
Yuyan Chen1, Qingqing Liu2, Miaomiao Wu2
1Class 2, Grade 13, Clinical Medicine, Medical College, Nantong University, Nantong, Jiangsu, 226001, People's Republic of China.
Abstract:
Grb2-associated binding protein 2 (GAB2), a key member of the family of Gab scaffolding adaptors, is important in the phospoinositide3-kinase (PI3K) and extracellular signal-regulated kinase (ERK) signaling pathways, and is closely associated with cell proliferation, cell transformation, and tumor progression. But its role in hepatocellular carcinoma (HCC) is still unknown. In this study, we investigated the expression of GAB2 and its potential clinical and biological significances in HCC. Western bolt and immunohistochemistrical analyses revealed that GAB2 was obviously upregulated in HCC tissues. Meanwhile, GAB2 was significantly associated with histological grade, tumor size, and the proliferation marker Ki-67 through our further analysis. The Kaplan-Meier survival curves also showed that increased GAB2 expression was directly correlated with poor prognosis in HCC patients and served as an independent prognostic marker of overall survival. Moreover, serum starvation-refeeding, RNA interference, CCK-8, EDU, colony formation, and flow-cytometry analyses were all performed with the purpose of investigating GAB2's regulation of HCC cell proliferation. Our results indicated that GAB2 progressively accumulated when cells entered into S phase. Consistently, cell proliferation was distinctly hindered by small interfering RNA. More interestingly, we discovered that GAB2 promoted cell proliferation by enhancing ERK signaling and GAB2-induced cell proliferation was inhibited by the inhibition of ERK activation. Finally, GAB2 was verified to be able to confer doxorubicin resistance in HCC cells. In summary, these data demonstrated that GAB2 might promote HCC cell proliferation by enhancing ERK signaling, and all above findings provided a potential therapeutic strategy for the treatment of HCC.
Insights
Grb2-associated binding protein 2 (GAB2) promotes hepatocellular carcinoma (HCC) cell proliferation by enhancing ERK signaling. Increased GAB2 expression correlates with poor prognosis and doxorubicin resistance in HCC patients, suggesting GAB2 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Grb2-associated binding protein 2 (GAB2) is a scaffolding adaptor protein involved in PI3K and ERK signaling pathways, crucial for cell proliferation and tumor progression.
- The role of GAB2 in hepatocellular carcinoma (HCC) remains largely unexplored, necessitating investigation into its expression and functional significance in this malignancy.
Purpose of the Study:
- To investigate the expression levels of GAB2 in HCC tissues.
- To determine the clinical and biological significance of GAB2 in HCC.
- To elucidate the role of GAB2 in HCC cell proliferation, signaling pathways, and drug resistance.
Main Methods:
- Western blot and immunohistochemistry were used to analyze GAB2 expression in HCC tissues.
- Kaplan-Meier survival analysis was performed to assess the prognostic value of GAB2.
- In vitro assays including RNA interference, CCK-8, EDU, colony formation, and flow cytometry were employed to study GAB2's effect on cell proliferation.
- ERK signaling pathway activation was assessed in relation to GAB2 expression.
Main Results:
- GAB2 was significantly upregulated in HCC tissues and correlated with higher histological grade, larger tumor size, and increased Ki-67 expression.
- Elevated GAB2 expression was associated with poor overall survival in HCC patients, identifying it as an independent prognostic marker.
- GAB2 accumulation during the S phase of the cell cycle promoted HCC cell proliferation, partly through the enhancement of ERK signaling.
- GAB2 conferred doxorubicin resistance to HCC cells.
Conclusions:
- GAB2 plays a critical role in promoting HCC cell proliferation and progression, likely by activating the ERK signaling pathway.
- GAB2 is a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma.
- Targeting GAB2 may offer a novel therapeutic strategy for improving HCC treatment outcomes and overcoming drug resistance.
Related Concept Videos
Mitogens and the Cell Cycle
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

